Article thumbnail

In Vitro Cultures of Schisandra chinensis (Turcz.) Baill. (Chinese Magnolia Vine)—a Potential Biotechnological Rich Source of Therapeutically Important Phenolic Acids

By Agnieszka Szopa and Halina Ekiert

Abstract

The contents of free phenolic acids and cinnamic acid were determined using an HPLC method in methanolic extracts from biomass of Schisandra chinensis (Turcz.) Baill. (Chinese magnolia vine) at different stages of organogenesis, cultured in vitro on a few variants of Murashige and Skoog (MS) medium, containing different concentrations of plant growth regulators 6-benzylaminopurine (BAP) and 1-naphthaleneacetic acid (NAA) (from 0.1 to 3.0 mg/l) and in extracts from overground parts of plants growing in vivo. Six of 12 analysed compounds were detected in all extracts: chlorogenic, p-coumaric, p-hydroxybenzoic, protocatechuic, salicylic and syringic acids. Total contents of the examined metabolites in biomass of shoot-differentiating callus culture cultivated on six MS medium variants were dependent on concentrations of growth regulators in the media and ranged from 14.90 to 60.05 mg/100 g d.w. Total contents of the compounds in biomass extracts from undifferentiating callus culture maintained only on two of six MS medium variants were higher and amounted to 74.54 and 78.24 mg/100 g d.w. Maximum total contents of phenolic acids in both types of in vitro cultures were greater than in fruits (55.73 mg/100 g d.w.) and leaves (4.55 mg/100 g d.w.) of plants gowning in vivo. Chlorogenic acid and salicylic acid were the main compounds identified in biomass extracts of shoot-differentiating callus cultures (max 22.60 and 21.17 mg/100 g d.w., respectively), while chlorogenic acid (max 38.43 mg/100 g d.w.) and protocatechuic acid (max 20.95 mg/100 g d.w.) prevailed in the extracts from undifferentiating callus cultures. Other compounds dominated in fruits, namely p-coumaric acid (23.36 mg/100 g d.w.) and syringic acid (14.96 mg/100 g d.w.). This is the first report on biochemical potential of cells from S. chinensis in vitro cultures to produce the biologically active phenolic acids. These are the first results on the analysis of this group of metabolites in overground parts of plants growing in vivo, too

Topics: Article
Publisher: Springer-Verlag
OAI identifier: oai:pubmedcentral.nih.gov:3324685
Provided by: PubMed Central

Suggested articles

Citations

  1. (2005). Ceská a Slovenská Farmacie,
  2. (1990). In
  3. (2007). Lek w Polsce.
  4. (1997). Medicinal natural products. A biosynthetic approach.
  5. (2011). National Formulary USP 34, NF 29. Appl Biochem Biotechnol
  6. (2011). Schisandrae chinensis fructus. European Directorate for the Quality of Medicines,
  7. (2012). Schisandrae chinensis fructus. Rzeczpospolita Polska,
  8. (2005). The pharmacopoeia of the People’s Republic of China.
  9. (2007). WHO monographs on selected medicinal plants.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.